These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374 [Abstract] [Full Text] [Related]
13. A phase I comparative postcoital testing study of three concentrations of C31G. Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R. Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892 [Abstract] [Full Text] [Related]
19. Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque. Patton DL, Sweeney YT, Balkus JE, Hillier SL. Sex Transm Dis; 2006 Nov; 33(11):691-5. PubMed ID: 16641825 [Abstract] [Full Text] [Related]
20. C31G, a new agent for oral use with potent antimicrobial and antiadherence properties. Corner AM, Dolan MM, Yankell SL, Malamud D. Antimicrob Agents Chemother; 1988 Mar; 32(3):350-3. PubMed ID: 3364952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]